Showing 431-440 of 804 results for "".
GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reVitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown.Diet and Inflammation in Dermatology
https://practicaldermatology.com/topics/other-dermatitis/diet-and-inflammation-in-dermatology/23008/Tinea Incognito, the Great Imitator: Case Reports
https://practicaldermatology.com/youngmd-connect/resident-resource-center/tinea-incognito-the-great-imitator-case-reports/23925/Updating Approaches to Psoriasis
https://practicaldermatology.com/topics/psoriasis/evaluating-the-state-of-psoriasis-care/21660/Recent guidelines from the National Psoriasis Foundation point to new directions in research and therapy that will continue to shape psoriasis therapy.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Cultural Competence in Dermatology
https://practicaldermatology.com/topics/skin-of-color/cultural-competence-in-dermatology/23591/Acknowledging cultural differences, keeping an open mind, and showing empathy go a long way toward improving the patient’s care experience.What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Building a Modern Dermatology Department
https://practicaldermatology.com/topics/practice-management/building-a-modern-dermatology-department/23099/How blending the best of private practice and academic medicine works for this pediatric dermatologist.New Rosacea Classification System Encourages
More Precise Assessment and Treatmenthttps://practicaldermatology.com/topics/practice-management/new-rosacea-classification-system-encourages-br-more-precise-assessment-and-treatment/20484/A look at the rationale behind the new classification system and what it means for clinicians.